These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2091930)

  • 1. Preliminary neuropsychological test results.
    de Sonneville LM; Schmidt E; Michel U; Batzler U
    Eur J Pediatr; 1990; 149 Suppl 1():S39-44. PubMed ID: 2091930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations.
    Huijbregts SC; de Sonneville LM; Licht R; van Spronsen FJ; Verkerk PH; Sergeant JA
    Neuropsychologia; 2002; 40(1):7-15. PubMed ID: 11595258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria.
    Schmidt E; Burgard P; Rupp A
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S82-6. PubMed ID: 8828617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level.
    Schmidt E; Rupp A; Burgard P; Pietz J; Weglage J; de Sonneville L
    J Clin Exp Neuropsychol; 1994 Oct; 16(5):681-8. PubMed ID: 7836491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria.
    Huijbregts S; de Sonneville L; Licht R; Sergeant J; van Spronsen F
    Dev Neuropsychol; 2002; 22(2):481-99. PubMed ID: 12537335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Event-related potential correlates of selective processing in early- and continuously-treated children with phenylketonuria: effects of concurrent phenylalanine level and dietary control.
    de Sonneville LM; Huijbregts SC; van Spronsen FJ; Verkerk PH; Sergeant JA; Licht R
    Mol Genet Metab; 2010; 99 Suppl 1():S10-7. PubMed ID: 20123462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A; Prevor MB; Callender G; Druin DP
    Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.
    Bartus A; Palasti F; Juhasz E; Kiss E; Simonova E; Sumanszki C; Reismann P
    Metab Brain Dis; 2018 Oct; 33(5):1609-1615. PubMed ID: 29948654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
    Anastasoaie V; Kurzius L; Forbes P; Waisbren S
    Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Executive functioning in children and adolescents with phenylketonuria.
    VanZutphen K; Packman W; Sporri L; Needham M; Morgan C; Weisiger K; Packman S
    Clin Genet; 2007 Jul; 72(1):13-8. PubMed ID: 17594394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological studies on adolescents with phenylketonuria returned to phenylalanine-restricted diets.
    Clarke JT; Gates RD; Hogan SE; Barrett M; MacDonald GW
    Am J Ment Retard; 1987 Nov; 92(3):255-62. PubMed ID: 3426836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term dietary interventions in children and adolescents with treated phenylketonuria: effects on neuropsychological outcome of a well-controlled population.
    Huijbregts SC; de Sonneville LM; Licht R; van Spronsen FJ; Sergeant JA
    J Inherit Metab Dis; 2002 Oct; 25(6):419-30. PubMed ID: 12555935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages.
    Romani C; Palermo L; MacDonald A; Limback E; Hall SK; Geberhiwot T
    Neuropsychology; 2017 Mar; 31(3):242-254. PubMed ID: 28240926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial.
    ten Hoedt AE; de Sonneville LM; Francois B; ter Horst NM; Janssen MC; Rubio-Gozalbo ME; Wijburg FA; Hollak CE; Bosch AM
    J Inherit Metab Dis; 2011 Feb; 34(1):165-71. PubMed ID: 21153445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria.
    Hood A; Grange DK; Christ SE; Steiner R; White DA
    Mol Genet Metab; 2014 Apr; 111(4):445-51. PubMed ID: 24568837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-attentive processing in children with early and continuously-treated PKU. Effects of concurrent Phe level and lifetime dietary control.
    de Sonneville LM; Huijbregts SC; Licht R; Sergeant JA; van Spronsen FJ
    J Inherit Metab Dis; 2011 Aug; 34(4):953-62. PubMed ID: 21541727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Executive function impairment in early-treated PKU subjects with normal mental development.
    Leuzzi V; Pansini M; Sechi E; Chiarotti F; Carducci C; Levi G; Antonozzi I
    J Inherit Metab Dis; 2004; 27(2):115-25. PubMed ID: 15159642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behaviour and school achievement in patients with early and continuously treated phenylketonuria.
    Stemerdink BA; Kalverboer AF; van der Meere JJ; van der Molen MW; Huisman J; de Jong LW; Slijper FM; Verkerk PH; van Spronsen FJ
    J Inherit Metab Dis; 2000 Sep; 23(6):548-62. PubMed ID: 11032330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.